Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2008-03-04
2008-03-04
Hartley, Michael G. (Department: 1617)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S009320, C424S009360, C424S009361, C424S009363
Reexamination Certificate
active
07338651
ABSTRACT:
Cyclen-based chelates can be used as contrast agents for multi-modal imaging of tissue cells. The cyclen-based chelates are preferably polyazamacrocyclic molecules formed from 1,4,7,10 tetraazacyclododecane (“cyclen”) having varying chelating ions, phosphoester chains, and light harvesting moieties. By changing the chelating ion, phosphoester chain length and/or the light harvesting moiety different imaging techniques, such as MRI, CT, fluorescence and absorption, x-ray and NIR, may be employed to image the tissue cells. Additionally, the cyclen-based chelates may be conjugated to provide for site-specific delivery of the cyclen-based chelate to the desired tissue cells. The cyclen-based chelates may also be delivered to the tissue cells by attaching the cyclen-based chelates to a polymeric delivery vehicle. Although these cyclen-based chelates have a wide variety of application, the preferred use is for imaging of cancer cells, such as brain cancer, for improving resection of a cancerous tissue.
REFERENCES:
patent: 5531978 (1996-07-01), Berg et al.
patent: 5630997 (1997-05-01), Sherry et al.
patent: 5928627 (1999-07-01), Kiefer
patent: 5998624 (1999-12-01), Goodman et al.
patent: 8901476 (1989-02-01), None
patent: WO 95/01346 (1995-01-01), None
patent: WO 99/25389 (1999-05-01), None
Griffin, J. M. M., et al. Tetrahedron Letters 2001, 42, 3823-3825.
Kozikowski, A. P., et al. J. Med. Chem. 1997, 40, 2435-2439.
Huber, “Fluorescently Detectable Magnetic Resonance Imaging Agents,” Bioconjugate Chem., American Chemical Society, vol. 9 (No. 2), p. 242-249, (1998).
Kozikowski, “Synthesis and Biology of a 7-Nitro-2,1,3-benzoxadiazol-4-yl Derivative of 2-Phenylindole-3-acetamide: A Fluorescent Probe for the Peripheral-Type Benzodiazepine Receptor,” Journal of Medicinal Chemistry , American Chemical Society, vol. 40 (No. 16), (Aug. 1, 1997).
Bornhop, “Simple, high yielding synthesis of trifunctional fluorescent lanthanide chelates,” Tetrahedron Letters, Elsevier Science Ltd., (2001).
Chappell, et al.; Synthesis, Characterization, and Evaluation of a Novel Bifunctional Chelating Agents for the Lead Isotopes 203Pb and 212Pb; Nuclear Medicine & Biology; 2000; vol. 27; pp. 93-100.
Manning, et al.; Facile, Efficient Conjugation of a Trifunctional Lanthanide Chelate to a Peripheral Benzodiazepine Receptor Ligand; Organic Letters; 2002; vol. 4, No. 7; pp. 1075-1078.
Baykal, et al.; Synthesis and Phosphodiester Transesterification Activity of the La3+-Complex of a Novel Functionalized Octadentate Ligand; Tetrahedron Letters; 1998; 39; pp. 5861-5864.
Geraldes, et al.; Relaxometry, Animal Biodistribution, and Magnetic Resonance Imaging Studies of Some New Gadolinium (III) Macrocyclic Phosphinate and Phosphonate Monoester Complexes; Academic Press; 1993; vol. 30, No. 6; pp. 696-703.
Griffin, et al.; Simple, High Yielding Synthesis of Trifunctional Fluorescent Lanthanide Chelates; Tetrahedron Letters; 2001; 42; pp. 3823-3825.
Bornhop Darryl J.
Goebel Timothy
Manning H. Charles
Hartley Michael G.
Myers, Jr. Richard S.
Ramachandran Umamaheswari
Stites & Harbison PLLC
Texas Tech University System
LandOfFree
Multi-use multimodal imaging chelates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-use multimodal imaging chelates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-use multimodal imaging chelates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2784227